Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

May 12, 2021 Press Releases

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group.

Jeff Smagula brings to Verrill years of industry experience he gained while serving in key posts at a global life sciences company and most recently at one of the top three health insurance plans in Massachusetts. He has deep experience with U.S. and international privacy regulations, export and trade compliance, Foreign Corrupt Practices Act compliance, provider reimbursement and health insurance, as well as the design, implementation, and operation of sophisticated compliance systems. From his in-house positions and through experience gained as a junior partner at the Boston office of a global law firm, Jeff dealt with an array of federal, state, and international administrative and regulatory agencies to help clients achieve their business and strategic objectives. With this background, Jeff Smagula is also uniquely positioned to assist clients confronting a variety of legal compliance risks and design by developing and enhancing legal compliance and privacy programs for participants in the health care and life sciences industries.

“We are delighted to welcome Jeff to our Health Care & Life Sciences Group,” said Michael K. Fee, Chair of Verrill’s Health Care & Life Sciences Group. “Jeff’s knowledge and experience in important areas such as domestic and international privacy regulations, complement and expand the reach of our talented team of lawyers serving the health care and life sciences industries, allowing us to continue providing innovative, responsive and cost-effective services and solutions to our clients, and meet their constantly-evolving needs. Consistent with Verrill’s longstanding commitments, Jeff also has proven himself to be a leader and champion of diversity, inclusion, equity and opportunity in the workplace and beyond,” Fee added.

Most recently, Jeff Smagula was Vice President, Chief Compliance and Ethics Officer at Tufts Health Plan and prior to that he served as Head of Trade Compliance and Assistant General Counsel at EMD Millipore Corporation. Jeff began his legal career as a member of the Litigation Department and Government Investigations Practice Group at WilmerHale LLP and while at the firm worked for six months as a Special Assistant District Attorney at the Middlesex County District Attorney’s Office.

Jeff earned a Bachelor of Arts degree with honors from Harvard College and a Juris Doctor with honors from the Georgetown University Law Center.

Firm Highlights


Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...


65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...


Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...


340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...


“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments


Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...


Patent Litigation: Medical Device

Defended company medical device manufacturer against claimed infringement of expired patent relating to laser hair removal; obtained stay of matter pending reexamination of patent, which resulted in cancelling of all allegedly infringing claims and...


HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...


The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...


Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors

In November 2020, Alicia Siani co-authored with C. James Watson, James D. Whitledge, and Michele M. Burns "Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors," published in Journal of Medical...

Contact Verrill at (855) 307 0700